VitriVax

VitriVax is a vaccine formulation technology company that develops innovative solutions to improve global access to vaccines. They utilize their proprietary ALTA® technology to create thermostable formulations, particularly focusing on combination pediatric vaccines. This technology allows for the co-formulation of multiple antigens in a single injection.

Buy Funded Startups lists

Funding Round: Grant

Funding Amount: $3.6M

Date: 04-Dec-2024

Investors: Bill & Melinda Gates Foundation

Markets: Biotechnology, Vaccine Technology, Medical, Medical Device, Therapeutics

HQ: Boulder, Colorado, United States

Founded: 2017

Website: https://vitrivaxbio.com/

LinkedIn: https://www.linkedin.com/company/vitrivax

Twitter: https://twitter.com/VitriVax

Instagram: